To Curb the Progression of Fatal COVID-19 Course—Dream or Reality Szymon PriceRadosław TargońskiRyszard Targoński Inflammation and Cardiovascular Diseases (A Kirabo, Section Editor) 27 February 2021 Article: 12
Blood Pressure Reduction in Hypertensive Acute Heart Failure Nicholas HarrisonPeter PangPhillip Levy Hypertension and Emergency Medicine (T Rainer and P Levy, Section Editors) 20 February 2021 Article: 11
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation Fosca Quarti-TrevanoGino SeravalleGuido Grassi Hypertension and the Kidney (RM Carey, Section Editor) Open access 13 February 2021 Article: 10
The COVID-19 Pandemic: an Appraisal of its Impact on Human Immunodeficiency Virus Infection and Pre-Eclampsia Rowen GovenderJagidesa MoodleyThajasvarie Naicker Preeclampsia (VD Garovic, Section Editor) 11 February 2021 Article: 9
Gut Microbiota-Derived Short-Chain Fatty Acids Facilitate Microbiota:Host Cross talk and Modulate Obesity and Hypertension Haley B. OverbyJane F. Ferguson Gut Microbiome and Hypertension (J Ferguson, Section Editor) 03 February 2021 Article: 8
Response to “Comment’s on the Story of the Silent Killer, a History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debate” Jonathan KalehoffSuzanne Oparil Letter to the Editor 03 February 2021 Article: 7
Comments on the Story of the Silent Killer, a History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debate Ali TaghizadiehReza Mohammadinasab Commentary 03 February 2021 Article: 6